In order to comply with the Commonwealth of Massachusetts’ Phase 1 reopening plan, hospital and health care providers must meet a set of standards and guidelines outlined by the Massachusetts Department of Public Health (DPH).

In order to comply with the Commonwealth of Massachusetts’ Phase 2 reopening plan, hospital and health care providers must meet a set of standards and guidelines outlined by the Massachusetts Department of Public Health (DPH).

In order to comply with the Commonwealth of Massachusetts’ Phase 3 reopening plan, hospital and health care providers must meet a set of standards and guidelines outlined by the Massachusetts Department of Public Health (DPH).

South Shore Health System, Inc. (“Applicant”) with a principal place of business at 55 Fogg Road, South Weymouth, MA 02190 intends to file a Notice of Determination of Need with the Massachusetts Department of Public Health for a change in service by South Shore Hospital (“SSH”). The project is for...

The Leapfrog Group rates hospital among the best in greater Boston and the U.S. for safety

Celebrating its 100th anniversary, the South Shore Hospital earns its seventh straight “A” grade from The Leapfrog Group, rating it among the best in Greater Boston and the U.S. for safety

In an effort to better serve the community of Weymouth, South Shore EMS has opened a new headquarters located at 60 Winter Street. The 14,453 square foot facility sits directly next door to the Weymouth Fire and Police Departments, helping to enhance the already strong relationship between the three...

It was a magical autumn evening under the stars as more than 400 turned out to support the Grayken Center for Treatment at South Shore Health at this year's Moonlight & Miracles Gala.

South Shore Health hosted its 17th annual Moonlight & Miracles Gala and raised close to $760,000 in support of Behavioral Health and Substance Use Disorder (SUD) Services. The total tops last year’s fundraising goal by more than $150,000!

With the region experiencing yet another surge in cases of COVID-19, the Mobile Integrated Health (MIH) program is participating in an innovative clinical trial that brings a much talked about drug to treat COVID-19 (remdesivir) to patients at home, instead of at the hospital.